MAPT and Alzheimer disease: According to the ATN (A: amyloid, T: phosphorylated tau, N: neurodegeneration) framework constructed by Jack and colleagues [14], the biomarkers amyloid β (Aβ) and phosphorylated tau are fundamental to the diagnosis of AD.